ESTINYL Drug Patent Profile
✉ Email this page to a colleague
When do Estinyl patents expire, and when can generic versions of Estinyl launch?
Estinyl is a drug marketed by Schering and is included in one NDA.
The generic ingredient in ESTINYL is ethinyl estradiol. There are twenty-six drug master file entries for this compound. Additional details are available on the ethinyl estradiol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ESTINYL?
- What are the global sales for ESTINYL?
- What is Average Wholesale Price for ESTINYL?
Summary for ESTINYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,895 |
| DailyMed Link: | ESTINYL at DailyMed |
Recent Clinical Trials for ESTINYL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Cancer Institute (NCI) | Phase 2 |
US Patents and Regulatory Information for ESTINYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | ESTINYL | ethinyl estradiol | TABLET;ORAL | 005292-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | ESTINYL | ethinyl estradiol | TABLET;ORAL | 005292-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | ESTINYL | ethinyl estradiol | TABLET;ORAL | 005292-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
